Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

14.3%

1 terminated out of 7 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

7Total
Not Applicable (4)
P 1 (1)
P 2 (1)
P 4 (1)

Trial Status

Recruiting5
Terminated1
Enrolling By Invitation1

Clinical Trials (7)

Showing 7 of 7 trials
NCT07491601Not ApplicableRecruiting

PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"

NCT06961071Phase 1Recruiting

Parathyroid Allotransplant for Treatment of Hypoparathyroidism

NCT07416149Not ApplicableRecruiting

Comparing PTeye-assisted Versus Conventional Total Thyroidectomy

NCT07381998Not ApplicableEnrolling By InvitationPrimary

Effects of Total Thyroid Removal on Parathyroid Function and Quality of Life

NCT06765941Not ApplicableRecruiting

PTeye vs Surgeons Eyes in Intraoperative Identification and Functional Preservation of Parathyroid Glands During Thyroid Surgery: A Parallel Randomized Controlled Clinical Trial.

NCT07034677Phase 4RecruitingPrimary

Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism

NCT01171690Phase 2TerminatedPrimary

Teriparatide for Postsurgical Hypoparathyroidism

Showing all 7 trials

Research Network

Activity Timeline